Skip to main content
. 2024 Mar 22;38(5):458–470. doi: 10.1177/02698811241237870

Figure 4.

Figure 4.

Baseline expectations for psilocybin and escitalopram for discontinuers and unmedicated patients separately. Boxes show medians, 25 and 75 percentiles. There is a trend for patients who discontinued having higher expectations for escitalopram.